Acute Kidney Injury (AKI)
Acute kidney injury is a sudden reduction in kidney function that impairs the body’s ability to regulate fluid balance, electrolytes, acid–base status, and waste excretion. Rather than representing a single disease, AKI is a syndrome that incorporates failure of renal perfusion, direct nephron injury, or obstruction to urine flow. AKI can develop rapidly, with systemic consequences appearing early, and even small declines in kidney function can destabilise multiple organ systems.
What You Need to Know
The kidneys maintain internal homeostasis through glomerular filtration and finely tuned tubular processes that regulate fluid balance, electrolytes, acid–base status, and waste removal. In acute kidney injury, this balance is disrupted, leading to accumulation of metabolic waste products, impaired electrolyte regulation, and unstable fluid handling. Reduced filtration may occur because of inadequate renal blood flow, intrinsic injury to nephron structures, or obstruction to urine outflow, but all three ultimately impair the kidney’s ability to maintain chemical and volume stability.
AKI represents loss of renal regulatory capacity rather than simple loss of filtration. This means patients may have preserved urine output while still developing dangerous biochemical abnormalities because tubular function is impaired and solute clearance is ineffective. In this setting, potassium, hydrogen ions, and uraemic toxins accumulate despite ongoing urine production.
The clinical impact of AKI arises from:
rising nitrogenous waste and uraemic toxins
electrolyte disturbances such as hyperkalaemia
acid–base imbalance
fluid overload or depletion
These derangements can rapidly destabilise cardiac, neurological, and metabolic function, which is why AKI is a medical emergency even when urine output appears relatively normal.
Beyond the Basics
Renal perfusion and autoregulatory failure
Under normal conditions, the kidneys maintain a relatively stable glomerular filtration rate despite changes in systemic blood pressure through powerful autoregulatory mechanisms. These include fine adjustments in afferent and efferent arteriolar tone and feedback from the macula densa that modulates filtration in response to tubular sodium delivery. This system ensures that waste clearance and electrolyte balance remain stable even when blood pressure fluctuates.
In acute kidney injury, these protective mechanisms become impaired. Hypovolaemia, reduced cardiac output, systemic vasodilation, or excessive vasoconstriction reduce renal perfusion pressure, eventually overwhelming autoregulation. Once blood flow falls below a critical threshold, glomerular filtration drops sharply, limiting waste removal and triggering sodium and water retention that further alters haemodynamics and tissue perfusion.
Tubular dysfunction and loss of selectivity
The renal tubules are among the most metabolically active cells in the body, making them particularly vulnerable to hypoxia, toxins, and inflammatory injury. In AKI, tubular epithelial cells lose their ability to maintain membrane polarity, transport electrolytes efficiently, and preserve the integrity of the tubular barrier. As transporters fail, sodium and water handling becomes disordered, and the kidney loses its ability to concentrate or dilute urine appropriately.
As cellular injury progresses, gaps appear in the tubular epithelium, allowing filtrate to leak back into the interstitium and circulation. This back-leak means that filtration may still occur at the glomerulus, but effective urine formation is reduced, explaining why biochemical abnormalities can worsen even when urine output remains relatively preserved.
Accumulation of toxins and metabolic waste
Reduced glomerular filtration leads to accumulation of urea, creatinine, and a wide range of other metabolic waste products. These uraemic toxins interfere with enzyme activity, immune function, and cellular metabolism throughout the body, producing neurological symptoms, gastrointestinal disturbance, and impaired host defence.
Beyond their direct toxic effects, these retained substances promote oxidative stress and inflammatory signalling, which further damages renal tissue and contributes to dysfunction in distant organs. AKI therefore acts not only as a consequence of systemic illness but also as a driver of ongoing physiological deterioration.
Electrolyte and acid–base derangement
The kidneys play a central role in regulating potassium, hydrogen ions, and bicarbonate. In AKI, impaired tubular secretion of potassium rapidly leads to hyperkalaemia, which destabilises cardiac conduction and increases the risk of fatal arrhythmias. At the same time, reduced hydrogen ion excretion and impaired bicarbonate regeneration produce metabolic acidosis that disrupts enzyme activity, myocardial contractility, and cellular metabolism.
These derangements may progress quickly and do not necessarily correlate with urine output, meaning patients can develop life-threatening biochemical abnormalities even when they are not overtly oliguric.
Inflammatory and microvascular injury
AKI is increasingly recognised as an inflammatory disease rather than purely a haemodynamic or toxic insult. Renal injury triggers cytokine release, leukocyte recruitment, and endothelial activation within the kidney, leading to microvascular dysfunction and capillary leak. These changes impair oxygen delivery to renal tissue, creating regional hypoxia that perpetuates tubular injury even after the initial insult has resolved.
This inflammatory response extends beyond the kidneys, contributing to lung injury, cardiovascular instability, and immune dysfunction. AKI therefore represents a systemic inflammatory state with widespread physiological consequences.
Adaptive and maladaptive responses
Early in AKI, sodium and water retention can help preserve circulating volume and maintain renal perfusion. Reduced filtration may also transiently limit toxin generation. However, when these responses persist, they become harmful, producing fluid overload, venous congestion, and increased renal interstitial pressure that further impairs perfusion.
This transition from short-term compensation to self-perpetuating injury marks the progression from mild to severe AKI and explains why early intervention to restore perfusion and limit tubular injury is critical to recovery.
Clinical Connections
Acute kidney injury commonly presents with a combination of reduced urine output, rising creatinine, and rapidly evolving metabolic disturbance, but its clinical impact often reflects loss of renal regulation rather than simple loss of filtration. Patients may appear haemodynamically unstable, confused, breathless, or oedematous as fluid, electrolytes, and acid–base balance deteriorate. AKI is especially dangerous because biochemical and cardiovascular instability can progress quickly, even when urine output is still preserved.
In practice, AKI is recognised and managed through:
rising urea and creatinine reflecting reduced clearance
hyperkalaemia, metabolic acidosis, and fluid overload driving cardiac and respiratory instability
oliguria or inappropriately normal urine output despite biochemical deterioration
hypotension, sepsis, heart failure, or nephrotoxic exposure as common precipitants
Management focuses on identifying and reversing the underlying cause, supporting renal perfusion, and preventing complications. This includes fluid resuscitation or diuresis as appropriate, avoidance of nephrotoxic drugs, correction of electrolyte and acid–base abnormalities, and treatment of infection or obstruction. In severe or refractory cases, renal replacement therapy is required to stabilise potassium, acid–base status, and fluid balance while renal recovery is supported.
Concept Check
Why can significant AKI occur despite preserved urine output?
How does impaired autoregulation contribute to reduced glomerular filtration?
Why are renal tubular cells particularly vulnerable to injury?
How does AKI lead to rapid electrolyte and acid–base imbalance?
Why is AKI considered a systemic inflammatory condition?